Clinical Trials · NCT00761332

Back Pain in Patients With Severe Osteoporosis

Name: Back Pain in Patients With Severe Osteoporosis
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedN/ATeriparatide

Phase: N/A
Recruitment status: Completed
Sponsor: Eli Lilly and Company
Enrollment: 650
Start date: Feb 2008
Locations: 15 sites, 9 countries
Primary endpoint: New or worsening back pain as measured by a specific question in the Back Pain Questionnaire

View Teriparatide compound reference